Fischkoff, Steven A.,Weiss, Roberta,Kempeni, Joachim,JOACHIM KEMPENI,STEVEN A. FISCHKOFF,ROBERTA WEISS
申请号：
AU2002314922
公开号：
AU2002314922C1
申请日:
2002.06.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Methods of treating disorders in which TNFα activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α(hTNFα) are disclosed. The antibody may be administered with or without methotrexate. These antibodies have high affinity for hTNFα (e.g., K
